Harwood Feffer LLP Announces Investigation Of American Medical Systems Holdings Inc.
Harwood Feffer LLP ( www.hfesq.com) is investigating potential claims in connection with American Medical Systems Holdings Inc. ("AAMS" or the "Company") (NASDAQ: AMMD - News) concerning the Company’s agreement to be acquired by Endo Pharmaceuticals Holdings Inc. (“Endo”) in a transaction valued at approximately $2.9 billion. The transaction is expected to close late in the third quarter of this year.
On April 11, 2011, AMS announced that it had entered into a definitive merger agreement with Endo. Under the terms of the deal, AMS stockholders will receive $30.00 in cash per share. Our investigation concerns whether there was a fair process to obtain fair consideration for the stockholders of AMS.
If you own common shares of AMS and would like to learn more about these claims or if you wish to discuss this matter and have any questions or information concerning this announcement, please contact Robert I. Harwood, Esq. at email@example.com or James G. Flynn, Esq. at firstname.lastname@example.org. You may also call them at (877) 935-7400. For more information about class actions, or to sign up online, please visit our website: www.hfesq.com.
Harwood Feffer LLP is a national shareholder litigation firm. Harwood Feffer LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.Attorney Advertising. © 2011 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP ( www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV